Answers are grounded in this paper and cite their sources.
Urinary tract infections (UTIs) are common, with up to 150 million global cases annually.UTIs manifest as pyelonephritis, cystitis, urethritis, and asymptomatic bacteriuria.The most common causative organisms in Kenya are E. coli, Klebsiella spp., and S. aureus.Distinguishing UTIs from urinary tract contaminations and colonizations, which do not require drug treatment, is crucial.Inappropriate empirical use of antibiotics to treat UTIs, including penicillins, cephalosporins, quinolones, and sulfamethoxazole-trimethoprim, has led to increasing cases of documented antimicrobial resistance (AMR) to these drugs in Kenya, especially the emergence of extended-spectrum β-lactamase (ESBL)-producing isolates, which also develop cross-resistance to other antibiotic classes.This creates serious multidrug-resistant (MDR) bacterial phenotypes that are very difficult to treat, may require last-resort antibiotics, and are associated with severe morbidity and mortality, with far-reaching socio-economic costs.In this study, we share the stories of 3 patients with MDR E. coli and Klebsiella spp.who were treated at a rural hospital in Kenya and look at how they were given antibiotics for UTIs in the year before they were diagnosed with MDR bacteria.We propose that such indiscriminate use of antibiotics possibly contributed to the isolation of the MDR organisms, which unfortunately could have led to the death of 2 of the patients.We underscore the need for institutional Antimicrobial Stewardship Programs (ASPs) as the answer to AMR.
No takes yet. Share an insight, caveat, or question.
Onyango et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: